AHSNs Support Implementation of Mobile ECG Devices to Reduce Atrial Fibrillation-Related Stroke
Mobile ECG devices are being funded by NHS England to support the national programme to reduce atrial fibrillation (AF) related stroke.
The programme is being supported by the Academic Health Science Networks (AHSNs) and runs alongside NHS England’s Innovation and Technology Tariff (ITT). A toolkit has been created to help implement the mobile ECG device AliveCorKardia which helps detect AF.
The ITT, which is also being supported by the AHSNs, was introduced by NHS England on 01 April 2017 to incentivise the adoption of innovation in the NHS. Through the Tariff, Innovations are funded by NHS England based on a reimbursement model or the number of uses. For example, care providers can order eligible innovations directly from the supplier at no cost then NHS England will reimburse the supplier directly.
NHS England has recently issued ITT technical notes which offer guidance for commissioners and providers on the themes, specifications, reimbursement and reporting requirements.
Implementation toolkits are also available for four innovations which meet the ITT’s specifications:
If you are interested in developing your AF pathway using mobile ECG devices, please email stuart.monk@swahsn.com
For more information about the ITT funding models and the innovations the SW AHSN will be supporting, click here
